Bariatric-Metabolic Surgery Utilisation in Patients With and Without Diabetes: Data from the IFSO Global Registry 2015-2018
Richard Welbourn 1, Marianne Hollyman 2, Robin Kinsman 3, John Dixon 4, Ricardo Cohen 5, John Morton 6, Amir Ghaferi 7, Kelvin Higa 8, Johan Ottosson 9, Francois Pattou 10, Salman Al-Sabah 11, Merhan Anvari 12, Jacques Himpens 13, Ronald Liem 14, Villy Våge 15, Peter Walton 3, Wendy Brown 16, Lilian Kow 17
Affiliations
Affiliations
- Department Upper GI and Bariatric Surgery, Musgrove Park Hospital, Taunton, TA1 5DA, UK. Richard.Welbourn@Somersetft.nhs.uk.
- Department Upper GI and Bariatric Surgery, Musgrove Park Hospital, Taunton, TA1 5DA, UK.
- Dendrite Clinical Systems Ltd., Henley-on-Thames, Oxfordshire, RG9 1AY, UK.
- Iverson Health Innovation Research Institute, Swinburne University, Melbourne, Australia.
- The Center for Obesity and Diabetes, Oswaldo Cruz German Hospital, São Paulo, Brazil.
- Division Chief, Bariatric and Minimally Invasive Surgery, Yale School of Medicine, New Haven, CT, USA.
- Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
- UCSF, Fresno, CA, USA.
- Department of Surgery, Faculty of Medicine and Health, Örebro University, Orebro, Sweden.
- Faculty of Medicine, University of Lille, Lille, France.
- Al-Amiri Hospital Kuwait, Royale Hyatt Hospital, Kuwait City, Kuwait.
- Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
- CHIREC Delta Hospital, Brussels, Belgium.
- Department of Surgery, Groene Hart Hospital, Gouda, Netherlands.
- Scandinavian Obesity Surgery Registry, Bergen, Norway.
- Centre of Obesity Research and Education, Monash University, Melbourne, Australia.
- College of Medicine and Public Health, Flinders University, Adelaide, Australia.
Abstract
Background: Comparative international practice of patients undergoing bariatric-metabolic surgery for type 2 diabetes mellitus (T2DM) is unknown. We aimed to ascertain baseline age, sex, body mass index (BMI) and types of operations performed for patients with T2DM submitted to the IFSO Global Registry.
Materials and methods: Cross-sectional analysis of patients having primary surgery in 2015-2018 for countries with ≥90% T2DM data completion and ≥ 1000 submitted records.
Results: Fifteen countries including 11 national registries met the inclusion criteria. The rate of T2DM was 24.2% (99,537 of 411,581 patients, country range 12.0-55.1%) and 77.1% of all patients were women. In every country, patients with T2DM were older than those without T2DM (overall mean age 49.2 [SD 11.4] years vs 41.8 [11.9] years, all p < 0.001). Men were more likely to have T2DM than women, odds ratio (OR) 1.68 (95% CI 1.65-1.71), p < 0.001. Men showed higher rates of T2DM for BMI <35 kg/m2 compared to BMI ≥35.0 kg/m2, OR 2.76 (2.52-3.03), p < 0.001. This was not seen in women, OR 0.78 (0.73-0.83), p < 0.001. Sleeve gastrectomy was the commonest operation overall, but less frequent for patients with T2DM, patients with T2DM 54.9% vs without T2DM 65.8%, OR 0.63 (0.63-0.64), p < 0.001. Twelve out of 15 countries had higher proportions of gastric bypass compared to non-bypass operations for T2DM, OR 1.70 (1.67-1.72), p < 0.001.
Conclusion: Patients with T2DM had different characteristics to those without T2DM. Older men were more likely to have T2DM, with higher rates of BMI <35 kg/m2 and increased likelihood of food rerouting operations.
Keywords: Bariatric surgery; Comorbidity; Demographic classification; IFSO Global Registry; Metabolic surgery; Obesity surgery; Operation choice for diabetes; Sex characteristics; Type 2 diabetes.
Conflict of interest statement
Dr Welbourn reports personal fees from Novo Nordisk, outside the submitted work.
Drs Kinsman and Walton report grants from IFSO, outside the submitted work.
Dr Dixon reports personal fees from NHMRC, during the conduct of the study; personal fees from Reshape, personal fees from Bariatric Advantage, personal fees from Novo Nordisk, personal fees from Nestle Health Science, personal fees from Johnson & Johnson, and personal feed from I-Nova, outside the submitted work.
Dr Cohen reports personal fees from GI Dynamics, grants from Johnson & Johnson Medical, Brazil, outside the submitted work.
Dr Ottosson reports consultancy fees from Johnson & Johnson and Vifor Pharma, outside the submitted work.
Dr Anvari reports consultancy fees from Johnson & Johnson, outside the submitted work.
Dr Himpens reports personal fees from Ethicon, personal fees from Medtronic, outside the submitted work.
Dr Brown reports grants from Johnson and Johnson, grants from Medtronic, grants from GORE, personal fees from GORE, grants from Applied Medical, grants from Apollo Endosurgery, grants and personal fees from Novo Nordisk, personal fees from Merck Sharpe and Dohme, outside the submitted work; and I am a bariatric surgeon so earn my living from performing these procedures.
Drs Hollyman, Morton, Ghaferi, Higa, Pattou, Al-Sabah, Liem, Våge, Kow have nothing to disclose.
Figures
Similar articles
Welbourn R, Pournaras DJ, Dixon J, Higa K, Kinsman R, Ottosson J, Ramos A, van Wagensveld B, Walton P, Weiner R, Zundel N.Obes Surg. 2018 Feb;28(2):313-322. doi: 10.1007/s11695-017-2845-9.PMID: 28822052
Welbourn R, Hollyman M, Kinsman R, Dixon J, Liem R, Ottosson J, Ramos A, Våge V, Al-Sabah S, Brown W, Cohen R, Walton P, Himpens J.Obes Surg. 2019 Mar;29(3):782-795. doi: 10.1007/s11695-018-3593-1. Epub 2018 Nov 12.PMID: 30421326
Tian P, Fu J, Li M, Liu Y, Bian S, Zhang M, Liu J, Jin L, Zhang Z, Zhang P.Diabetes Obes Metab. 2023 Apr;25 Suppl 1:27-33. doi: 10.1111/dom.15012. Epub 2023 Mar 6.PMID: 36789640
McGlone ER, Carey I, Veličković V, Chana P, Mahawar K, Batterham RL, Hopkins J, Walton P, Kinsman R, Byrne J, Somers S, Kerrigan D, Menon V, Borg C, Ahmed A, Sgromo B, Cheruvu C, Bano G, Leonard C, Thom H, le Roux CW, Reddy M, Welbourn R, Small P, Khan OA.PLoS Med. 2020 Dec 7;17(12):e1003228. doi: 10.1371/journal.pmed.1003228. eCollection 2020 Dec.PMID: 33285553 Free PMC article.
Jans A, Szabo E, Näslund I, Ottosson J, Näslund E, Stenberg E.Surg Obes Relat Dis. 2022 Mar;18(3):305-312. doi: 10.1016/j.soard.2021.12.005. Epub 2021 Dec 8.PMID: 34974997 Review.
Cited by
Brodersen K, Nielsen MF, Richelsen B, Lauritzen ES, Pahle E, Abrahamsen J, Hartmann B, Holst JJ, Møller N.J Diabetes Res. 2022 Dec 21;2022:5476454. doi: 10.1155/2022/5476454. eCollection 2022.PMID: 36589629 Free PMC article. Clinical Trial.
Zou Q, Wei C, Shao Z, Wang H, Xiao Z, Cao L, Mei Z, Zhao W, Jiang Z, Chen Z.Front Oncol. 2022 Nov 21;12:1001662. doi: 10.3389/fonc.2022.1001662. eCollection 2022.PMID: 36479064 Free PMC article.
Can we abandon foregut exclusion for an ideal and safe metabolic surgery?
Widjaja J, Chu Y, Yang J, Wang J, Gu Y.Front Endocrinol (Lausanne). 2022 Nov 10;13:1014901. doi: 10.3389/fendo.2022.1014901. eCollection 2022.PMID: 36440199 Free PMC article. Review.
Porat D, Azran C, Kais H, Dahan A.J Clin Med. 2021 Nov 29;10(23):5627. doi: 10.3390/jcm10235627.PMID: 34884328 Free PMC article.
Network Meta-Analysis of Metabolic Surgery Procedures for the Treatment of Obesity and Diabetes.
Currie AC, Askari A, Fangueiro A, Mahawar K.Obes Surg. 2021 Oct;31(10):4528-4541. doi: 10.1007/s11695-021-05643-z. Epub 2021 Aug 7.PMID: 34363144 Free PMC article.
References
-
- Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. NEJM. 2017;376:641–51. 10.1056/NEJMoa1600869.
-
- Hofsø D, Fatima F, Borgeraas H, et al. Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a singlecenter, triple-blind, randomized controlled trial. Lancet Diabetes Endocrinol. 2019;7(12):912–24. - PubMed
-
- Stegenga H, Haines A, Jones K, et al. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ. 2014;349:g6608. - PubMed
-
- Welbourn R, Hopkins J, Dixon JB, et al. Commissioning guidance for weight assessment and management in adults and children with severe complex obesity. Obes Rev. 2018;19:14–27. - PubMed
-
- Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Diabetes Care. 2016;39(6):861–77. 10.2337/dc16-0236. - PubMed
-
- Rubino F, Shukla A, Pomp A, et al. Bariatric, Metabolic, and diabetes surgery: what’s in a name? Ann Surg. 2014;259:117–22. 10.1097/SLA.0b013e3182759656. - PubMed
-
- Buchwald H, Varco RL. Metabolic surgery (modern surgical monographs): Grune & Stratton; 1978. ISBN 10: 0808910779 / ISBN 13: 9780808910770
-
- Xia Q, Campbell JA, Ahmad H, et al. Bariatric surgery is a cost-saving treatment for obesity-a comprehensive meta-analysis and updated systematic review of health economic evaluations of bariatric surgery. Obes Rev. 2020;21(1):e12932. - PubMed
-
- Welbourn R, le Roux CW, Owen-Smith A, et al. Why the NHS should do more bariatric surgery; how much should we do? BMJ. 2016;353:i1472. 10.1136/bmj.i1472. - PubMed
-
- Welbourn R, Pournaras DJ, Dixon J, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Second IFSO Global Registry Report 2013-2015. Obes Surg. 2018;28:313–22. - PubMed
-
- Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29(3):782–95. 10.1007/s11695-018-3593-1. - PubMed
-
- Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg 2004;14:1157-64 - PubMed
-
- Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg. 2009;19:1605–11. - PubMed
-
- Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427–36. - PubMed
-
- Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32. - PubMed
-
- Angrisani L, Santonicola A, Iovino P, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94. - PubMed
-
- Welbourn R, Gagner M, Naslund I, et al. First IFSO Global Registry Report 2014. Henley-on-Thames: Dendrite Clinical Systems Ltd; 2014. ISBN 978-0-9568154-9-1
-
- Ramos A, Kow L, Brown W, Welbourn R, Dixon J, Kinsman R et al. Fifth IFSO Global Registry Report 2019. ISBN 978-1-9160207-3-3. https://www.ifso.com/pdf/5th-ifso-global-registry-report-september-2019.pdf
-
- Non-Communicable Diseases Risk Factor Collaboration (NCD-RisC). http://ncdrisc.org/data-downloads-diabetes.html. Accessed 30 March 2020
-
- Centers for Disease Control and Prevention. National Diabetes Statistics Report 2020 Estimates of Diabetes and its Burden in the United States. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-stat... Accessed 20 May 2020
-
- International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: 2019. https://www.diabetesatlas.org. Accessed 20 May 2020
-
- Martin M, Beekley A, Kjorstad R, et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6:8e15. - PubMed
-
- Kumar SB, Hamilton BC, Wood SG, et al. Is laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass? A comparison of 30-day complications using the MBSAQIP data registry. Surg Obes Relat Dis. 2018;14:264–9. - PubMed
-
- Chaar ME, Lundberg P, Stoltzfus J. Thirty-day outcomes of sleeve gastrectomy versus Roux-en-Y gastric bypass: first report based on Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database. Surg Obes Relat Dis. 2018;14(5):545–51. 10.1016/j.soard.2018.01.011. - PubMed
-
- Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. NEJM. 2015;373:11–22. - PubMed
-
- Dixon JB. Regional differences in the coverage and uptake of bariatric-metabolic surgery: a focus on type 2 diabetes. Surg Obes Relat Dis. 2016;12(6):1171–7. - PubMed
-
- De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSO Position Statement. Obes Surg. 2018;28(5):1188–206. 10.1007/s11695-018-3182-3. - PubMed
-
- Sakran N, Sherf-Dagan S, Blumenfeld O, et al. Incidence and risk factors for mortality following bariatric surgery: a Nationwide Registry Study [published correction appears in Obes Surg. 2018 Apr 25;]. Obes Surg. 2018;28(9):2661–9. 10.1007/s11695-018-3212-1. - PubMed